Jiangxi Biological Products Research Institute

Jiangxi Biological Products Research Institute is a specialized Chinese biopharmaceutical company that focuses on the research, development, and commercialization of vaccines and therapeutic antisera. Founded in 1969 and based in Nanchang, the institute is a leading domestic provider of critical emergency biologicals, including tetanus antitoxin, anti-rabies serum, and a variety of snake antivenins. The company operates extensive GMP-certified manufacturing facilities and utilizes advanced equine-derived antibody purification technologies. Since its acquisition by Boya Bio-pharmaceutical Group, the institute has leveraged its parent company's resources to expand its market presence and enhance its R&D pipeline. It remains a vital component of China's public health infrastructure for infectious disease prevention and emergency medical treatment.